Biopolymer compositions, scaffolds and devices
Compositions and blends of biopolymers and copolymers are described, along with their use to prepare biocompatible scaffolds and surgically implantable devices for use in supporting and facilitating the repair of soft tissue injuries.
1. A method for facilitating repair of a damaged ligament or tendon, comprising the step of fastening an implantable scaffold to the ligament or tendon such that the scaffold provides mechanical support to the area of repair,
said implantable ligament and tendon repair device comprises an annealed biopolymer sheet having substantially aligned electrospun biopolymer fibers,
wherein the biopolymer fibers comprise about 15 to 40% by weight of Type I collagen and about 60 to 85% by weight of a biodegradable copolymer selected from the group consisting of PLLA, PDLA, PDLLA, PLGA, poly(glycolic acid) and mixtures thereof; and
wherein the biopolymer fibers are not cross-linked.
2. The method of claim 1 , wherein the ligament or tendon is selected from the group consisting of Achilles tendon, rotator cuff tendon, patellar tendon, bicep tendon or quadricep tendon.
3. The method of claim 2 , wherein the ligament or tendon is the Achilles tendon.
4. The method of claim 1 , wherein the biodegradable copolymer is PDLLA.
5. The method of claim 1 wherein the biodegradable copolymer is PLLA.
6. The method of claim 1 , wherein the biodegradable copolymer is PDLA.
7. The method of claim 1 , wherein the biodegradable copolymer is PDLLA.
8. The method of claim 1 , wherein the biodegradable copolymer is PLGA.
9. The method of claim 1 , wherein the biodegradable copolymer is poly(glycolic acid).
10. The method of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have a range of tensile strength of about 4 to 16 MPa.
11. The method of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have a modulus of elasticity of about 35 to 750 MPa.
12. The method of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have a peak stress of about 11 to 15.2 MPa.
13. The method of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have a strain to failure of 50-200% (0.5 to 2.0 mm/mm) as tensile tested at 1 mm/s in hydrated condition.
14. The method of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have an average diameter of about 700 nm to about 1,500 nm.
15. The method of claim 1 , wherein the Type I collagen is selected from the group consisting of atelocollagen, telocollagen, recombinant human collagen and mixtures thereof.